Chronic Lymphoid Leukemia

12 clinical trials · Condition

Record	Firm	Date
Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL (NCT04883749)	German CLL Study Group	2021-06-01
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL) (NCT04608318)	German CLL Study Group	2021-03-01
The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide (NCT03804372)	Gruppo Italiano Malattie EMatologiche dell'Adulto	2020-07-07
Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A (NCT03766763)	French Innovative Leukemia Organisation	2019-05-22
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning (NCT03852407)	University of Liege	2019-02-04
Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients With Relapsed/Refractory CLL (NCT03787264)	German CLL Study Group	2019-01-14
The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases (NCT01518959)	Semmelweis University	2012-01-01
Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers (NCT00788684)	AbbVie	2009-07-21
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies (NCT00406809)	AbbVie (prior sponsor, Abbott)	2006-11-01

Track Chronic Lymphoid Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.